MeganMcKnelly

Associate

Washington + 1.202.879.3825

Connect:

Share

Megan McKnelly advises national and international companies on a variety of intellectual property and technology matters, including IP licenses, mergers, acquisitions, corporate restructurings, and strategic alliances.

Megan has experience in domestic and foreign intellectual property due diligence and portfolio analysis, as well as drafting and negotiating agreements involving software and cloud-related services, complex collaborations, and the sale, purchase, or license of intellectual property and technology assets. She has represented clients in a variety of technological fields, including pharmaceuticals, medical devices, telecommunications, cloud computing, fintech, streaming services, smart devices, and the Internet of Things (IoT).

Megan has an active pro bono practice that includes representing a human trafficking survivor in a vacatur petition in federal district court and an individual seeking recovery for civil rights violations in the Ninth Circuit.

Experience

  • TransDigm completes additional $550 million Senior Secured Notes offering and reprices $6.2 billion of existing tranche H and I term loansJones Day represented TransDigm Group Incorporated (“TransDigm Group”), a leading global designer, producer, and supplier of highly engineered aircraft components, in connection with the Rule 144A and Regulation S offering by TransDigm Inc., its wholly-owned subsidiary, of an additional $550 million aggregate principal amount of 6.375% Senior Secured Notes due 2029 (the “Notes”).
  • TransDigm completes $4.4 billion Senior Secured Notes offering and extension and increase of its revolving credit facility to $910 millionJones Day represented TransDigm Group Incorporated (“TransDigm Group”), a leading global designer, producer and supplier of highly engineered aircraft components, in connection with the Rule 144A and Regulation S offering by TransDigm Inc., its wholly-owned subsidiary, of $2.2 billion aggregate principal amount of 6.375% Senior Secured Notes due 2029 and $2.2 billion aggregate principal amount of 6.625% Senior Secured Notes due 2032 (collectively, the “Notes”).
  • Astellas enters into strategic collaboration and license agreement with Kelonia Therapeutics to develop novel immuno-oncology therapeuticsJones Day represented Xyphos Biosciences, Inc. (a wholly-owned subsidiary of Astellas Pharma Inc.) in connection with a research collaboration and license agreement with Kelonia Therapeutics, Inc. ("Kelonia"), a biotech company pioneering new genetic medicines using its in vivo gene placement system (iGPS®).
  • VSE Corporation sells Federal and Defense Services operating assetsJones Day advised VSE Corporation in the sale of substantially all of its Federal and Defense Services operating assets.
  • P&G sells Vidal Sassoon brand in Greater ChinaJones Day is advising The Procter & Gamble Company in the sale of its Vidal Sassoon hair care consumer products business to Henkel AG & Co. KGaA.
  • Koch reaches agreement to acquire Wever fertilizer plant from OCI GlobalJones Day is advising Koch Ag & Energy Solutions, LLC, an affiliate of Koch Industries, Inc., in the $3.6 billion acquisition of Iowa Fertilizer Company (IFCO) from OCI N.V., a Netherlands-based producer and distributor of hydrogen products.
  • Sanofi and Janssen collaborate to develop vaccines for extra-intestinal pathogenic E. coliJones Day represented and supported Sanofi's in-house team in its strategic collaboration with Janssen Pharmaceuticals, now "Johnson & Johnson Innovative Medicine," in connection with a Co-Development, Co-Commercialization & License Agreement with Johnson & Johnson's Janssen Pharmaceuticals relating to the development and commercialization of vaccines for extra-intestinal pathogenic E. coli.
  • restor3d acquires Conformis, Inc.Jones Day advised restor3d, Inc., a leading personalized 3D-printed orthopedic company, on its acquisition of Conformis, Inc. (NASDAQ: CFMS), a leading medical technology company focused on orthopedic patient care.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Astellas enters into strategic collaboration and exclusive option license agreement with ImmunoPrecise Antibodies Ltd.Jones Day represented Xyphos Biosciences, Inc. (a wholly owned subsidiary of Astellas Pharma Inc., "Astellas") in connection with a research collaboration and exclusive option license agreement with ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company.
  • Ahlström Capital makes strategic investment in Bast Fibre TechnologiesJones Day advised Ahlström Capital in its acquisition of 20% of Bast Fibre Technologies Inc., a manufacturer of 100% plant-based, intact natural fibres with the technical and performance requirements for a wide variety of nonwoven applications.
  • EagleTree Capital acquires MacKenzie-Childs from Castanea PartnersJones Day advised EagleTree Capital in the acquisition and financing of MacKenzie-Childs, the artisan-driven American heritage home decor brand, from Castanea Partners.
  • ACI Worldwide divests corporate online banking solutionsJones Day advised ACI Worldwide, Inc. in the $100 million divestiture of its corporate online banking solutions to One Equity Partners.
  • NerdWallet acquires On The Barrelhead for $120 millionJones Day advised NerdWallet, Inc. (Nasdaq: NRDS), a platform that provides financial guidance to consumers and small- and mid-sized businesses, in its acquisition of On the Barrelhead, Inc. for total consideration of $120 million, consisting of approximately $70 million in cash and $50 million in NerdWallet Class A common stock.
  • Sonepar sells Vallen Distribution to Nautic PartnersJones Day represented the Sonepar Group – a Paris-headquartered global leader in B-to-B distribution of electrical products, solutions and related services – in the sale of Sonepar's subsidiary business, Vallen Distribution, to Nautic Partners, a middle-market private equity firm based in Rhode Island.
  • City of Hope acquires Cancer Treatment Centers of AmericaJones Day advised City of Hope, a world-renowned, National Cancer Institute (NCI)-designated comprehensive cancer research and treatment organization, in connection with its acquisition of Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers across the United States.
  • EagleTree Capital acquires Andronaco IndustriesJones Day advised EagleTree Capital in the acquisition and financing of Andronaco Industries, a leading provider of corrosion-resistant flow control technologies.
  • Husqvarna acquires Orbit IrrigationJones Day advised Husqvarna AB on the acquisition of Lunar Holding Corporation ("Orbit Irrigation") for $480 million in cash.
  • Milliken & Company acquires Encapsys, LLCJones Day advised Milliken & Company in its acquisition of Encapsys, LLC, a world leader in microencapsulation delivery systems for the building, construction, paper, bedding and personal care industries.
  • Solmax acquires TenCate GeosyntheticsJones Day advised Groupe Solmax Inc. (Solmax), the global leader in the production of high-quality polyethylene geomembranes for industrial and environmental applications, and its shareholders (including institutional investors Caisse de dépot et placement du Québec and Fonds de Solidarité FTQ), in connection with Solmax’s acquisition of TenCate Geosynthetics Holding B.V., a global provider of geosynthetics and industrial fabrics, from Dutch conglomerate Koninklijke Ten Cate (Royal Ten Cate, the Netherlands), and advised on the related senior secured financing to support the acquisition.
    • View All

    April 2021 Commentary

    United States Imposes New Sanctions on Russia

    April 2021 Alert

    Commerce Reduces Requirements Relating to Mass-Market Encryption Items and Publicly Available Software

    March 2021 Alert

    GSA's Use of DoD Cybersecurity Language for Future Contracts Signals Increased Security Requirements in Civilian Contracts

    March 2021 Commentary

    Commerce Department Rule Authorizes Review of ICTS Transactions Involving "Foreign Adversaries"

    February 2021 White Paper

    Protecting AI Innovations Through Trade Secrets and Patent Protection

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.